News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ChanTest Corporation First To Offer New High Throughput Electrophysiology Platform Validated for Both VGICs and LGICs


4/6/2011 10:41:39 AM

CLEVELAND--(BUSINESS WIRE)--Beginning next month, ChanTest Corporation will offer the highest throughput electrophysiology platform on the market validated for both voltage-gated (VGIC) and rapidly desensitizing ligand-gated ion channels (LGICs). LGICs typically are not well suited for automated platform assays but by using the first IonWorks Barracudaâ„¢ System ever sold by Molecular Devices, ChanTest adds even greater capacity to its state of the art screening operation. A unique, flow-through well design and rapid solution exchange rate allows for accurate automated LGIC screening.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES